21 May 2009
Liver transplantation in two children with severe hepatic graft versus host disease after hematopoietic stem cell transplantationJ Teisseyre, M Teisseyre, P Kaliciński, B Wolska-Kusnierz, M Markiewicz-Kijewska, H Ismail, I Jankowska, M Szymczak
Ann Transplant 2009; 14(1): 41-42 :: ID: 880349
Backgound: Graft versus host disease (GVHD), a common complication of
hematopoietic stem cell transplantation (HSCT), frequently causes liver injury and in some cases leads to an end stage liver disease. Some authors have suggested that extra hepatic GVHD (skin and intestinal) should be a contraindication to liver transplantation (OLTx) because of a poor survival of these patients. The aim of the study is to present a successful OLTx in two patients with severe chronic GVHD after HSCT.
Material/Method: First case: 8- years-old boy received MUD HSCT due to CD40
ligand deficiency complicated by chronic Cryptosporidium infection with cholangitis sclerosans. GVHD III/IV degree occured 8 days after HSCT. Vanishing bile duct syndrome caused liver failure. Successful OLTx was performed 11 months later after resolution of skin and intestinal symptoms of GVHD. Second case: 6 month old boy with X-linked severe combined immunodeficiency received MUT HSCT. GVHD III degree occured 26 days after HSCT. Six months later, when skin and intestinal symptoms had been resolved, living related OLTx was successfully performed due to an end stage liver involvement.
Results: Both patients have good liver function, full immunological reconstitution and haven't GVHD symptoms respectively six months and four years after OLTx. Conclusions: OLTx appears to be an effective treatment for post HSCT GVHD even when both hepatic and extra hepatic symptoms are present.
Keywords: Liver Transplantation, Stem Cell Transplantation, case report
Most Viewed Current Articles
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588